Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MYBPC2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
mRNA | CYR61 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0007 |
mRNA | GIGYF1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
mRNA | ZC3H13 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
mRNA | RELB | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
mRNA | CHSY1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
mRNA | TRPV5 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
mRNA | TRPM8 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
mRNA | CBLN3 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
mRNA | L1TD1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |